C
Cumulus Neuroscience
Accelerating CNS Clinical Trials
About Cumulus Neuroscience
We’re developing faster, more effective tools to help our partners solve the biggest healthcare challenges in neurodegeneration and psychiatry. Cumulus Neuroscience has created a next-generation integrated physiological and digital biomarker platform. In clinical trials it provides the critical data and insights needed to accelerate the delivery of more effective CNS drugs to patients. This addresses the significant unmet need for faster, more robust and cost-effective execution and evaluation of clinical trials in neuroscience.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2015
- Headquarters
- Belfast, United Kingdom
- Employees
- 35
- Open positions
- None listed
- Dealroom signal
- 83.3/100
- Industry
- Health
- Sub-industry
- BioTechnology, Medical Devices, Health Platform
- Sector
- Biotech & Life Sciences, Biotechnology, Neurology, Cognitive, Clinical Trials, Tech for Biotech and Pharma, AI Drug Discovery, biotech medtech and e-health, Techbio
- Business model
- Manufacturing
- Client focus
- B2B
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| LATE VC✓Equity / VC | Jul 2025 | $4.3M | $73M | Clarendon Fund Managers · Whiterock Finance · ACF Investors | ↗ |
| GRANT✓Other financing | May 2024 | $1.6M | — | UK Research and Innovation | — |
Growth signals
Latest recorded traffic for Cumulus Neuroscience is 190 monthly website visits, down 72.5% over the last three months. Cumulus Neuroscience's team grew 2.9% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Cumulus Neuroscience in the Belfast ecosystem
The Cumulus Neuroscience office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed8 investors entered at this stage
Techstart Ventures
ACF Investors
Invest Northern Ireland
Kx Systems
Par Equity
Clarendon Fund Managers
British Business Investments
UK Research and Innovation
Series A4 investors entered at this stage
SV Health Investors
Dementia Discovery Fund
Future Fund
LifeArc
Series B and later1 investor entered at this stage
Whiterock Finance
Other known investors2 additional known investors
Tech Nation
PXN Group
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Cumulus Neuroscience on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Cumulus Neuroscience’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.









